These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9532129)

  • 1. Differential effect of leflunomide on concordant xenogeneic islet graft rejection and recurrence of autoimmune diabetes.
    Guo Z; Mital D; Shen J; Chong AS; Tian Y; Foster P; Sankary H; McChesney L; Jensik SC; Williams JW
    Transplant Proc; 1998 Mar; 30(2):463-4. PubMed ID: 9532129
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppression preventing concordant xenogeneic islet graft rejection is not sufficient to prevent recurrence of autoimmune diabetes in nonobese diabetic mice.
    Guo Z; Mital D; Shen J; Chong AS; Tian Y; Foster P; Sankary H; McChesney L; Jensik SC; Williams JW
    Transplantation; 1998 May; 65(10):1310-4. PubMed ID: 9625011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of leflunomide and cyclosporine on concordant xenogeneic islet transplantation in streptozotocin-induced and autoimmune diabetic mice.
    Guo Z; Chong AS; Tian Y; Shen J; Yin D; Mital D; Foster P; Sankary H; McChesney L; Jensik S; Williams JW
    Transplant Proc; 1997 Jun; 29(4):2155. PubMed ID: 9193568
    [No Abstract]   [Full Text] [Related]  

  • 4. Leflunomide and its analogue X920715 synergize with cyclosporin A in preventing early graft failure and delaying graft rejection of xenogeneic islets in nonobese diabetic mice.
    Gysemans C; Waer M; Laureys J; Bouillon R; Mathieu C
    Transplant Proc; 2001 May; 33(3):2094-5. PubMed ID: 11377464
    [No Abstract]   [Full Text] [Related]  

  • 5. Leflunomide-based immunosuppression for porcine islet xenotransplantation.
    Mital D; Guo Z; Tian Y; Shen J; Podlasek W; Foster P; Sankary H; Jensik S; McChesney L; Chong A; Olack B; Williams J
    Transplant Proc; 1998 Mar; 30(2):515. PubMed ID: 9532154
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful discordant pancreatic islet xenotransplantation by prevention of primary nonfunction graft rejection and autoimmune disease recurrence.
    Henretta J; Pittman K; McFadden T; Thomas F
    Transplant Proc; 1994 Jun; 26(3):1133-4. PubMed ID: 8029859
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
    Guo Z; Wu T; Kirchhof N; Mital D; Williams JW; Azuma M; Sutherland DE; Hering BJ
    Transplantation; 2001 Jun; 71(11):1656-65. PubMed ID: 11435979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive effects of leflunomide and tacrolimus in prevention of islet xenograft rejection.
    Zhang L; Qi Z; Wu D; Shan S; Ekberg H
    Scand J Immunol; 2004 Mar; 59(3):255-60. PubMed ID: 15030575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression with leflunomide and cyclosporine prevents pig-to-rat islet xenograft rejection.
    Wennberg L; Wallgren AC; Sundberg B; Rafael E; Zhu S; Liu J; Tibell A; Karlsson-Parra A; Groth CG; Korsgren O
    Transplant Proc; 1995 Dec; 27(6):3314-5. PubMed ID: 8539967
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of diabetes recurrence after syngeneic islet transplantation in NOD mice by analogues of 1,25(OH)2D3 in combination with cyclosporin A: mechanism of action involves an immune shift from Th1 to Th2.
    Mathieu C; Casteels K; Waer M; Laureys J; Valckx D; Bouillon R
    Transplant Proc; 1998 Mar; 30(2):541. PubMed ID: 9532170
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
    Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
    Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Fas in recurrence of autoimmune diabetes after islet transplantation.
    Guo Z; Shen J; Mital D; Hong Y; Jensik SC; Williams JW
    Transplant Proc; 1999; 31(1-2):622. PubMed ID: 10083264
    [No Abstract]   [Full Text] [Related]  

  • 13. Early graft failure of xenogeneic islets in NOD mice is accompanied by high levels of interleukin-1 and low levels of transforming growth factor-beta mRNA in the grafts.
    Gysemans CA; Waer M; Valckx D; Laureys JM; Mihkalsky D; Bouillon R; Mathieu C
    Diabetes; 2000 Dec; 49(12):1992-7. PubMed ID: 11117999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreas islet xenografts but not allografts are resistant to autoimmune disease recurrence following islet transplantation.
    Thomas FT; Pittman K; Brezina P; Wu J; Mountz J; Contreras J; Thomas J
    Transplant Proc; 1997; 29(1-2):760-1. PubMed ID: 9123513
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of immunosuppressive drugs in islet xenotransplantation: leflunomide in combination with cyclosporine and mycophenolate mofetil prevents islet xenograft rejection in the pig-to-rat model.
    Wennberg L; Karlsson-Parra A; Sundberg B; Rafael E; Liu J; Zhu S; Groth CG; Korsgren O
    Transplantation; 1997 May; 63(9):1234-42. PubMed ID: 9158015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful xenotransplantation of adult porcine islets in NOD and BALB/c mice with leflunomide and cyclosporine.
    Mital D; Guo Z; Chong AS; Fu Z; Tian Y; Foster PF; Jensik S; Shen J; Sankary HN; McChesney LP; Williams JW
    Transplant Proc; 1997 Jun; 29(4):2166-7. PubMed ID: 9193573
    [No Abstract]   [Full Text] [Related]  

  • 17. Triple drug treatment with cyclosporine, leflunomide and mycophenolate mofetil prevents rejection of pig islets transplanted into rats and primates.
    Wennberg L; Groth CG; Tibell A; Zhu S; Liu J; Rafael E; Söderlund J; Biberfeld P; Morris RE; Karlsson-Parra A; Korsgren O
    Transplant Proc; 1997 Aug; 29(5):2498. PubMed ID: 9270824
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of xenograft resistance to autoimmune disease recurrence after pancreas islet transplantation.
    Thomas F; Pittman K; Larkin E; Berzina P; Contreras J; Quarantillo P; Thomas J
    Transplant Proc; 1999; 31(1-2):964-5. PubMed ID: 10083429
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of streptozotocin on autoimmune diabetes in NOD mice.
    Koulmanda M; Qipo A; Auchincloss H; Smith RN
    Clin Exp Immunol; 2003 Nov; 134(2):210-6. PubMed ID: 14616779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of autoimmune islet allograft destruction by engraftment of donor T cells.
    Bartlett ST; Schweitzer EJ; Kuo PC; Johnson LB; Delatorre A; Hadley GA
    Transplantation; 1997 Jan; 63(2):299-303. PubMed ID: 9020334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.